Concepedia

Megan Wind‐Rotolo

MW

Statistics

Publications

71

Citations

14.2K

H-Index

41

Active since

2001

Affiliations

Bristol-Myers Squibb (United States)(Current)

Dana-Farber Cancer Institute

Johns Hopkins University

Memorial Sloan Kettering Cancer Center

Harvard University

Megan Wind‐Rotolo is an author at Bristol-Myers Squibb (United States) specializing in cancer immunotherapy, oncology, and immunotherapy.

ORCID

Publications per year

2001–2024

71

Publications

71

Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma

Robert J. Motzer, Nizar M. Tannir, Osvaldo Arén Frontera et al. · New England Journal of Medicine · 2018 · 4.6K citations · Full text

, , +11

Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma

Diana Miao, Claire A. Margolis, Wenhua Gao et al. · Science · 2018 · 1.3K citations · Full text

, , +17

Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection

Mark Sulkowski, David Gardiner, M. Rodríguez‐Torres et al. · New England Journal of Medicine · 2014 · 1.2K citations

, , +13

Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma

David A. Braun, Yue Hou, Ziad Bakouny et al. · Nature Medicine · 2020 · 1K citations · Full text

, , +16

Preliminary Study of Two Antiviral Agents for Hepatitis C Genotype 1

Anna S. Lok, David Gardiner, Eric Lawitz et al. · New England Journal of Medicine · 2012 · 609 citations · Full text

, , +16

1–5 of 71